Find us at Booth #55432
Venetian Expo @ Level 2
Digital Health / January 6-9, 2026
As a global leader in non-invasive neurotechnology, we're debuting OhmBody, the first consumer wearable designed to gently engage nerve pathways studied for their role in menstrual comfort, stress response, emotional steadiness, digestive well-being, and overall cycle experience.
This is where women’s health meets neurotech. And it’s unlike anything the CES floor has seen.
Why OhmBody Matters
For decades, the menstrual wellness category has barely evolved. Heat pads. Painkillers. Tracking apps. Supplements. That’s the list.
Meanwhile, up to 90% of women experience multiple challenges throughout their cycle — yet no mainstream solution supports the whole-body menstrual experience.
Until now.
OhmBody introduces a completely new category: Wearable Menstrual Neurostimulation that is:
Clinical Research Results
Spark Biomedical (OhmBody parent company) published recent peer-reviewed pilot clinical research evaluating transcutaneous auricular neurostimulation (tAN) in women experiencing menstrual challenges.
When participant’s clinical study menstrual cycles were compared to baseline cycles, researchers observed the following trends:
Statistically significant, favorable differences reported across measures related to comfort, mood, and productivity
A New Category for Retail
Women are searching for real solutions — not more trackers, TENS devices, supplements or heating pads. Retailers are searching for differentiated products. OhmBody introduces the first technology-forward solution that supports total menstrual wellness.
Ideal for:
FOR PRESS & MEDIA COVERING CES
OhmBody is debuting the world’s first consumer-ready wearable for lighter, shorter, more comfortable periods—powered by neuroscience.
We’re available for interviews, booth walk-throughs, product demos, and expert commentary on:
Access high-resolution images, founder bios, science summaries, and brand assets in our media kit.